Quantitative & Derivatives Strategy
Flows & Liquidity : Equity market concentration and the shift from active to passive funds
May 2, 2024
Flows & Liquidity : Equity market concentration and the shift from active to passive funds
Flows & Liquidity : Equity market concentration and the shift from active to passive funds
This document is being provided for the exclusive use of blake@sandboxfp.com.
02 May 2024

This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan.

Flows & Liquidity

Equity market concentration and the shift from active to passive funds

J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.


  • We are sceptical of the thesis that the shift from active to passive is being reinforced by increasing US equity market concentration.
  • While active funds appear to be overall UW the ‘Magnificent 7’ stocks, they have managed to outperform their benchmarks both during 2023 and YTD, there is little sign of the active to passive shift having accelerated as a share of AUM.
  • The SEC diversification rule may not be as critical as it might seem taken at face value.
  • This week’s yen interventions may imply that Japanese authorities would have to consume a greater amount of foreign currency reserves to have the same impact as before.
  • Retail investors retrench from both equity and crypto markets.

  • The shift from active to passive equity funds continues unabated with active equity mutual funds bearing the brunt of equity fund selling in April. A question often arising in our client conversations is whether the shift from active to passive equity funds is reinforced by US equity market concentration and the rise of Magnificent seven stocks. The argument being that as active equity managers struggle to catch up with the rising weight of US large tech stocks and as they face the SEC’s diversification rule or their own stock/sector limits, they are forced to limit their exposure to the largest US tech stocks, which in turn makes it more difficult to outperform benchmarks in the current juncture. This in turn induces end investors such as retail investors to shift even more towards passive equity funds which, by simply tracking equity indices, do not face such concentration constraints. And this flow shift creates a self-reinforcing circle: as more money goes into passive equity funds it ends up in large tech stocks, which then expand further, becoming even bigger components of equity indices.

  • While we are sympathetic to some of the above arguments, we are sceptical of the overall thesis.
  • It is certainly the case that there has been an increased concentration since the onset of the pandemic when looking at the share of the so-called ‘Magnificent 7’ (Apple, Amazon, Alphabet, Meta, Microsoft, NVIDIA and Tesla) as a share of total S&P 500 market capitalisation (Figure 1). It is also evident in their shares of total S&P 500 earnings, though perhaps less so in terms of sales. Interestingly, while there is a perception that the large tech companies are ‘defensives’, the earnings as a % of total S&P earnings do exhibit cyclicality in the upswing in 2020/21, the correction in 2022 and from mid-2023 onward. This suggests they may be somewhat less defensive than commonly perceived. And when we take the difference between the Magnificent 7 share of S&P market cap and their share of revenues, equity market concentration has not made any new highs beyond the step increase seen after the pandemic (Figure 2).

Figure 1: Magnificent 7 share of S&P 500 market capitalisation, earnings and sales

In %.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 2: Difference between market capitalisation and sales shares of the Magnificent 7 share in the S&P 500

In %.

Source: Bloomberg Finance L.P., J.P. Morgan.

  • Second, while it is true that share of Magnificent 7 stocks is overall higher in passive vs active funds (by adding up the weights in Figure 3 we get 26% overall allocation for active funds vs 29% for passive funds), the biggest US active equity mutual fund managers have managed to outperform their benchmarks during 2023 and YTD, as shown by Figure 4 and Figure 5. This perhaps reflect their UWs in Apple and Tesla and their OWs in Microsoft and Google, as shown in Figure 3. For example, if we apply the allocations in Magnificent 7 stocks shown in Figure 3, we find that active funds would have slightly outperformed passive funds YTD.

Figure 3: Share of active and passive equity funds’ holdings* in Magnificent 7 stocks relative to their total holdings of stocks in the S&P 500 index*

In %. As on 1st May 24.

Source: Bloomberg Finance L.P., J.P Morgan.
* where active and passive ownership is specifically identified, excludes ‘unknown’ management style holdings.

Figure 4: Annual median excess return vs. benchmark of 100 biggest active US equity mutual funds

In %.

Source: Bloomberg Finance L.P., J.P Morgan.

Figure 5: Share of 100 biggest active US equity mutual funds beating their benchmark

In %.

Source: Bloomberg Finance L.P., J.P Morgan.

  • Third, the shift from active to passive equity funds has been taking place for some time and the trend does not appear to be accelerating due to the rise of Magnificent 7 stocks (Figure 6). Indeed, while there has been an acceleration in the outflow from active funds in nominal terms, with an increase in outflows in 2016 to $390bn having accelerated to around $500bn in 2020, 2022 and 2023, this is largely due to a price effect. The outflows relative to AUM, which rose to just over 6% in 2016, have been similar in magnitude in recent years.

Figure 6: Share of active vs. passive in equity US domiciled funds

As % of total AUM. Active and passive funds are US domiciled. Passive funds include ETFs. Last obs. is Mar’24.

Source: ICI, J.P. Morgan.

  • Fourth, the SEC diversification rule itself is perhaps not as critical as it seems on surface for three reasons. A) Our understanding of the SEC diversification rule is that up to 25% of fund assets can be held as large holdings (i.e. stocks with more than 5% of fund’s assets). This leaves room for active funds to have a few large exposures of >5% such as in Microsoft, Apple, Nvidia. B) Even if the room under this 25% rule is exhausted, funds have the option to re-categorise themselves as “non-diversified” and appeal to investors for picking the highest quality/highest return potential stocks (as successful equity long/short hedge funds and non-diversified active equity managers argue). And there is no evidence that end investors mind stock concentration. A simple fund search shows that less than 10% of US active equity mutual funds use “diversified” in their fund description. And after all, end investors have been pouring money into equity index ETFs and equity long/short hedge funds despite high/rising concentrations. C) While the SEC rule limits the addition of new exposure to individual stocks once the thresholds have been breached, as we note above active funds on aggregate are seeing outflows as part of the shift from active to passive. Active funds seeing outflows could simply sell other stocks to return cash to investors and increase their exposure to the magnificent 7 stocks beyond the above thresholds in a passive way.
  • In all, we are sceptical of the thesis that the shift from active to passive is being reinforced by increasing US equity market concentration. While active funds appear to be overall UW the Magnificent 7 stocks, they have managed to outperform their benchmarks both during 2023 and YTD, there is little sign of the active to passive shift having accelerated as a share of AUM. And the SEC diversification rule may not be as critical as it might seem taken at face value.

This week’s yen interventions may imply that Japanese authorities would have to consume a greater amount of foreign currency reserves to have the same impact as before

  • Japanese authorities appear to have intervened twice this week in periods of thin liquidity , on Monday 29th of April during a Japanese holiday and in late New York trading on May 1st . In both days the dollar dropped by around 5 yen intraday. We do not yet have information about the size of the intervention on May 1st, but press reports and the reported daily projection of changes in current account balances at the Bank of Japan point to around JPY6tr of intervention on April 29th . Provisional daily data on BoJ’s projected current account balances (that are subject to revisions) point to somewhat smaller intervention amount on May 1st of around JPY4tr, bringing this week’s total intervention to around JPY10tr. That said, the provisional figures for the intervention on Monday were subsequently revised higher.
  • This compares to a total intervention of around JPY9tr during Sep/Oct 2022 (in three series interventions on Sep 22nd , Oct 21st and Oct 24th 2022). At the time JPY2.8tr was used for Sep 22nd , JPY5.6tr for Oct 21st and JPY0.7tr for Oct 24th. Each of those three interventions had caused an immediate (but temporary) drop in the dollar of around 5-6 yen. The intervention last Monday April 29th 2024 had caused an immediate (and again temporary) drop in the dollar of around 5 yen. So at face value and assuming the size was JPY6tr as suggested by press reports and daily current account balances, last Monday’s intervention was somewhat less impactful per each trillion yen bought than the Sep/Oct 2022 interventions overall. In turn this may imply that Japanese authorities would have to consume a greater amount of foreign currency reserves to have the same impact.
  • In terms of how the intervention was funded, typically it is dollar deposits (like those held by the MoF at the Fed’s reverse repo facility) that are consumed during the actual intervention. That said, the lesson from the Sep/Oct 2022 interventions is that these deposits tend to be replenished relative quickly by the MoF eventually selling dollar securities. In other words, some downward pressure in short-dated USTs is likely as dollar securities are eventually sold in the days/weeks following this week’s interventions.
  • Indeed during the Sep/Oct 2022 interventions while at the time of the actual interventions dollar deposits were likely consumed, cumulatively over these two months the item “Deposits with Foreign central banks and BIS” at MoF’s Official Reserve Assets was roughly unchanged at around $136bn between Aug 31st 2022 and Oct 31st 2022. That is, dollar deposits were replenished within days or weeks by the MoF likely selling USTs. Instead the market value of “Securities” at the MoF’s foreign currency reserves had declined from $1037bn Aug 31st 2022 to $941bn Oct 31st 2022. Surely a significant part of this $96bn market value reduction was due to price changes as UST yields had increased by 100bp at the time. Assuming duration of 3 years for the dollar securities held as reserves, a 100bp increase in UST yields would imply a loss of around 3 x 100bp =3% or $31bn, so the remaining $96bn-$31bn=$65bn reduction in the market value of “Securities” in Japan’s foreign currency reserve assets would be due to sales to fund the intervention. This estimate is comparable to the actual intervention amount of JPY9.2tr during Sep/Oct 2022.
  • Similar to Sep/Oct 2022 the intervention did little in changing investors attitudes towards Japanese assets. Institutional investors, both offshore and onshore, continue to hold elevated Japanese equity exposures ( Figure 7 to Figure 9), roughly neutral positions in JGBs ( Figure 10) and very negative positions in the yen ( Figure 11 and Figure 12).
  • We recommend our readers to also see the latest notes by our yen strategist Junya Tanase.

Figure 7: Position proxy for offshore Nikkei futures

‘000 contracts.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 8: Position proxy for onshore Nikkei futures

‘000 contacts.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 9: Tokyo Stock Exchange margin trading - total buys minus total sells

In bn of shares. Topix on right axis.

Source: Tokyo Stock Exchange, Bloomberg Finance L.P., J.P. Morgan.

Figure 10: Position Proxy for 10Y JGB futures

Number of contracts in thousands across all expiries. Cumulative weekly absolute change in open interest multiplied by the sign of the futures price change every week.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 11: Position Proxy for JPY futures

Number of contracts in thousands across all expiries. Cumulative weekly absolute change in open interest multiplied by the sign of the futures price change every week.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 12: Average of longer- and shorter-term momentum signals for Yen

z-score of the momentum signal in our Trend Following Strategy framework shown in Tables A3 and A4 in the Appendix. Average of shorter- and longer-term momentum.

Source: Bloomberg Finance L.P., J.P. Morgan.

Retail investors retrench from both equity and crypto markets

  • We had argued in our previous publication F&L April 17th that the bitcoin halving was priced in and there was likely to be downside pressure on bitcoin prices post halving for three reasons:
      1. Still overbought conditions as per our futures position proxy.
      2. Bitcoin prices still well above our vol adjusted comparison to gold ($45k, see F&L March 7th ) or its medium term projected production cost post halving once unprofitable miners retrench ($42k, see F&L Feb 28th).
      3. Subdued crypto VC funding YTD despite the crypto resurgence
  • The past two weeks saw significant selling/profit taking  with perhaps retail investors playing a bigger role than institutional investors. In fact retail investors appear to have sold both crypto and equity assets during April.  Indeed, not only have spot bitcoin ETFs seen outflows in April ( Figure 13) but our proxies of the retail impulse into equities have also downshifted over the past month. This is shown by Figure 14 to Figure 18. Figure 14 highlights the net flow into equity funds including ETFs and mutual funds, typically used by retail investors,. The net flow into equity funds turned negative in April after strong buying in February and March.   Figure 15 depicts  small traders’ option flows for exchange-traded individual equity options in the US which has also downshifted in recent weeks. This is a proxy for the net flow into call options by US retail investors i.e. option customers with less than 10 contracts. The data come from OCC, the world’s largest equity derivatives clearing organisation and are weekly, with the week ending April 26th the last available observation. Figure 16 highlights the relative performance of 50% Nasdaq + 50% Russell 2000 basket vs. the S&P500 Index, which has also declined in recent weeks consistent with retail investors selling, given that Nasdaq and Russell 2000 stocks are the preferred habitats of US retail investors. Figure 17  shows the relative performance of US Retail Investors' Favorites US equity basket vs. S&P500 Index has also declined in recent weeks consistent with retail investors sell-off. Finally, the swings we observe in US retail investors’ sentiment surveys such as the AAII survey (shown in Figure 18) has swung from bullish to bearish territory last month.
  • In terms of institutional investors, it has been mostly momentum traders such as CTAs or other quantitative funds taking profit on previous extreme long positions in both bitcoin and gold, as shown by our momentum traders’ positioning proxies of Figure 19.
  • However, the overall positioning across our futures as shown in Figure 20 declined by less than our momentum signals in Figure 19 suggesting a more limited position reduction by other institutional investors outside quantitative funds/CTAs.
  • In all, with a lack of positive catalysts , with the retail impulse dissipating and with the three headwinds mentioned previously in our publication ( elevated positioning , high bitcoin prices vs gold and vs the estimated bitcoin production cost, subdued crypto VC funding ) still in place, we maintain a cautious stance on crypto markets over the near term.

Figure 13: Net flows in US spot bitcoin ETFs by month

$bn

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 14: Global Equity fund flows by month

$bn

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 15: Exchange-traded Call Option Buys at Open minus Sells at Open for Costumers with less than 10 contracts for options on individual equities

In mn contracts. Last obs is for the week ending 26th Apr 2024.

Source: OCC, J.P. Morgan

Figure 16: Performance of 50% Nasdaq + 50% Russell 2000 vs. S&P500 Index

Ratio of two return indices

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 17: Retail Investors’ Favorites US equity basket vs. S&P500 Index

Ratio of two return indices

Source: GS, Bloomberg Finance L.P., J.P. Morgan

Figure 18: AAII US Investor Sentiment Index, Bullish over Bearish ratio

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 19: Our momentum signals for gold and bitcoin futures, average of long and short lookback periods

z-score in y axis.

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 20: Implied cumulative position build up by speculative inventors in gold and CME bitcoin futures

In $bn.

Source: Bloomberg Finance L.P., J.P. Morgan.

Appendix

ETF Flow Monitor (as of 1st May)

Short Interest Monitor

Chart A11a: Cross Asset Volatility Monitor 3m ATM Implied Volatility (1y history) as of 30th Apr-2024

This table shows the richness/cheapness of current three-month implied volatility levels (red dot) against their one-year historical range (thin blue bar) and the ratio to current realised volatility. Assets with implied volatility outside their 25th/75th percentile range (thick blue bar) are highlighted. The implied-to-realised volatility ratio uses 3-month implied volatilities and 1-month (around 21 trading days) realised volatilities for each asset.

Spec position monitor

Mutual fund and hedge fund betas

CTAs – Trend following investors’ momentum indicators

Corporate Activity

Pension fund and insurance company flows

Credit Creation

Bitcoin monitor

Japanese flows and positions

Commodity flows and positions

Corporate FX hedging proxies

Non-Bank investors’ implied allocations

Analyst Certification: The Research Analyst(s) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFIA requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.

All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.

Important Disclosures

Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan–covered companies, and certain non-covered companies, by visiting https://www.jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request.

Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe: J.P. Morgan uses the following rating system: Overweight (over the duration of the price target indicated in this report, we expect this stock will outperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); Neutral (over the duration of the price target indicated in this report, we expect this stock will perform in line with the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); and Underweight (over the duration of the price target indicated in this report, we expect this stock will underperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe. NR is Not Rated. In this case, J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-Australia and ex-India) and U.K. small- and mid-cap Equity Research, each stock’s expected total return is compared to the expected total return of a benchmark country market index, not to those Research Analysts’ coverage universe. If it does not appear in the Important Disclosures section of this report, the certifying Research Analyst’s coverage universe can be found on J.P. Morgan’s Research website, https://www.jpmorganmarkets.com.

J.P. Morgan Equity Research Ratings Distribution, as of April 06, 2024

Overweight(buy) Neutral(hold) Underweight(sell)
J.P. Morgan Global Equity Research Coverage* 48% 39% 14%
    IB clients** 49% 45% 35%
JPMS Equity Research Coverage* 46% 42% 12%
    IB clients** 70% 66% 52%

*Please note that the percentages may not add to 100% because of rounding.**Percentage of subject companies within each of the "buy," "hold" and "sell" categories for which J.P. Morgan has provided investment banking services within the previous 12 months. For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P. Morgan representative, or email research.disclosure.inquiries@jpmorgan.com. For material information about the proprietary models used, please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are available to download on the company pages of our client website, http://www.jpmorganmarkets.com. This report also sets out within it the material underlying assumptions used.

A history of J.P. Morgan investment recommendations disseminated during the preceding 12 months can be accessed on the Research & Commentary page of http://www.jpmorganmarkets.com where you can also search by analyst name, sector or financial instrument.

Analysts' Compensation: The research analysts responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.

Registration of non-US Analysts: Unless otherwise noted, the non-US analysts listed on the front of this report are employees of non-US affiliates of J.P. Morgan Securities LLC, may not be registered as research analysts under FINRA rules, may not be associated persons of J.P. Morgan Securities LLC, and may not be subject to FINRA Rule 2241 or 2242 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account.

Other Disclosures

J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide.

UK MIFID FICC research unbundling exemption: UK clients should refer to UK MIFID Research Unbundling exemption for details of J.P. Morgan’s implementation of the FICC research exemption and guidance on relevant FICC research categorisation.

All research material made available to clients are simultaneously available on our client website, J.P. Morgan Markets, unless specifically permitted by relevant laws. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research material available on a particular stock, please contact your sales representative.

Any long form nomenclature for references to China; Hong Kong; Taiwan; and Macau within this research material are Mainland China; Hong Kong SAR (China); Taiwan (China); and Macau SAR (China).

J.P. Morgan Research may, from time to time, write on issuers or securities targeted by economic or financial sanctions imposed or administered by the governmental authorities of the U.S., EU, UK or other relevant jurisdictions (Sanctioned Securities). Nothing in this report is intended to be read or construed as encouraging, facilitating, promoting or otherwise approving investment or dealing in such Sanctioned Securities. Clients should be aware of their own legal and compliance obligations when making investment decisions.

Any digital or crypto assets discussed in this research report are subject to a rapidly changing regulatory landscape. For relevant regulatory advisories on crypto assets, including bitcoin and ether, please see https://www.jpmorgan.com/disclosures/cryptoasset-disclosure.

An analyst listed on the front cover has personal holdings in digital or crypto assets.

The author(s) of this research report may not be licensed to carry on regulated activities in your jurisdiction and, if not licensed, do not hold themselves out as being able to do so.

Exchange-Traded Funds (ETFs): J.P. Morgan Securities LLC (“JPMS”) acts as authorized participant for substantially all U.S.-listed ETFs. To the extent that any ETFs are mentioned in this report, JPMS may earn commissions and transaction-based compensation in connection with the distribution of those ETF shares and may earn fees for performing other trade-related services, such as securities lending to short sellers of the ETF shares. JPMS may also perform services for the ETFs themselves, including acting as a broker or dealer to the ETFs. In addition, affiliates of JPMS may perform services for the ETFs, including trust, custodial, administration, lending, index calculation and/or maintenance and other services.

Options and Futures related research: If the information contained herein regards options- or futures-related research, such information is available only to persons who have received the proper options or futures risk disclosure documents. Please contact your J.P. Morgan Representative or visit https://www.theocc.com/components/docs/riskstoc.pdf for a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options or http://www.finra.org/sites/default/files/Security_Futures_Risk_Disclosure_Statement_2018.pdf for a copy of the Security Futures Risk Disclosure Statement.

Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates

Private Bank Clients: Where you are receiving research as a client of the private banking businesses offered by JPMorgan Chase & Co. and its subsidiaries (“J.P. Morgan Private Bank”), research is provided to you by J.P. Morgan Private Bank and not by any other division of J.P. Morgan, including, but not limited to, the J.P. Morgan Corporate and Investment Bank and its Global Research division.

Legal entity responsible for the production and distribution of research: The legal entity identified below the name of the Reg AC Research Analyst who authored this material is the legal entity responsible for the production of this research. Where multiple Reg AC Research Analysts authored this material with different legal entities identified below their names, these legal entities are jointly responsible for the production of this research. Research Analysts from various J.P. Morgan affiliates may have contributed to the production of this material but may not be licensed to carry out regulated activities in your jurisdiction (and do not hold themselves out as being able to do so). Unless otherwise stated below, this material has been distributed by the legal entity responsible for production. If you have any queries, please contact the relevant Research Analyst in your jurisdiction or the entity in your jurisdiction that has distributed this research material.

Legal Entities Disclosures and Country-/Region-Specific Disclosures: Argentina: JPMorgan Chase Bank N.A Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (“BCRA”- Central Bank of Argentina) and Comisión Nacional de Valores (“CNV”- Argentinian Securities Commission - ALYC y AN Integral N°51). Australia: J.P. Morgan Securities Australia Limited (“JPMSAL”) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by the Australian Securities and Investments Commission and is a Market Participant of ASX Limited, a Clearing and Settlement Participant of ASX Clear Pty Limited and a Clearing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of JPMSAL only to "wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be found by visiting https://www.jpmm.com/research/disclosures. J.P. Morgan seeks to cover companies of relevance to the domestic and international investor base across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation sizes. If applicable, in the course of conducting public side due diligence on the subject company(ies), the Research Analyst team may at times perform such diligence through corporate engagements such as site visits, discussions with company representatives, management presentations, etc. Research issued by JPMSAL has been prepared in accordance with J.P. Morgan Australia’s Research Independence Policy which can be found at the following link: J.P. Morgan Australia - Research Independence Policy. Brazil : Banco J.P. Morgan S.A. is regulated by the Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Ombudsman J.P. Morgan: 0800-7700847 / 0800-7700810 (For Hearing Impaired) / ouvidoria.jp.morgan@jpmorgan.com. Canada : J.P. Morgan Securities Canada Inc. is a registered investment dealer, regulated by the Canadian Investment Regulatory Organization and the Ontario Securities Commission and is the participating member on Canadian exchanges. This material is distributed in Canada by or on behalf of J.P.Morgan Securities Canada Inc. Chile: Inversiones J.P. Morgan Limitada is an unregulated entity incorporated in Chile. China: J.P. Morgan Securities (China) Company Limited has been approved by CSRC to conduct the securities investment consultancy business. Dubai International Financial Centre (DIFC) : JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - The Gate, West Wing, Level 3 and 9 PO Box 506551, Dubai, UAE. This material has been distributed by JP Morgan Chase Bank, N.A., Dubai Branch to persons regarded as professional clients or market counterparties as defined under the DFSA rules. European Economic Area (EEA): Unless specified to the contrary, research is distributed in the EEA by J.P. Morgan SE (“JPM SE”), which is authorised as a credit institution by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). JPM SE is a company headquartered in Frankfurt with registered address at TaunusTurm, Taunustor 1, Frankfurt am Main, 60310, Germany. The material has been distributed in the EEA to persons regarded as professional investors (or equivalent) pursuant to Art. 4 para. 1 no. 10 and Annex II of MiFID II and its respective implementation in their home jurisdictions (“EEA professional investors”). This material must not be acted on or relied on by persons who are not EEA professional investors. Any investment or investment activity to which this material relates is only available to EEA relevant persons and will be engaged in only with EEA relevant persons. Hong Kong : J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong, and J.P. Morgan Broking (Hong Kong) Limited (CE number AAB027) is regulated by the Securities and Futures Commission in Hong Kong. JP Morgan Chase Bank, N.A., Hong Kong Branch (CE Number AAL996) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission, is organized under the laws of the United States with limited liability. Where the distribution of this material is a regulated activity in Hong Kong, the material is distributed in Hong Kong by or through J.P. Morgan Securities (Asia Pacific) Limited and/or J.P. Morgan Broking (Hong Kong) Limited. India : J.P. Morgan India Private Limited (Corporate Identity Number - U67120MH1992FTC068724), having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz - East, Mumbai – 400098, is registered with the Securities and Exchange Board of India (SEBI) as a ‘Research Analyst’ having registration number INH000001873. J.P. Morgan India Private Limited is also registered with SEBI as a member of the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited (SEBI Registration Number – INZ000239730) and as a Merchant Banker (SEBI Registration Number - MB/INM000002970). Telephone: 91-22-6157 3000, Facsimile: 91-22-6157 3990 and Website: http://www.jpmipl.com. JPMorgan Chase Bank, N.A. - Mumbai Branch is licensed by the Reserve Bank of India (RBI) (Licence No. 53/ Licence No. BY.4/94; SEBI - IN/CUS/014/ CDSL : IN-DP-CDSL-444-2008/ IN-DP-NSDL-285-2008/ INBI00000984/ INE231311239) as a Scheduled Commercial Bank in India, which is its primary license allowing it to carry on Banking business in India and other activities, which a Bank branch in India are permitted to undertake. For non-local research material, this material is not distributed in India by J.P. Morgan India Private Limited. Compliance Officer: Spurthi Gadamsetty; spurthi.gadamsetty@jpmchase.com; +912261573225. Grievance Officer: Ramprasadh K, jpmipl.research.feedback@jpmorgan.com; +912261573000.

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Indonesia : PT J.P. Morgan Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is registered and supervised by the Otoritas Jasa Keuangan (OJK). Korea : J.P. Morgan Securities (Far East) Limited, Seoul Branch, is a member of the Korea Exchange (KRX). JPMorgan Chase Bank, N.A., Seoul Branch, is licensed as a branch office of foreign bank (JPMorgan Chase Bank, N.A.) in Korea. Both entities are regulated by the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS). For non-macro research material, the material is distributed in Korea by or through J.P. Morgan Securities (Far East) Limited, Seoul Branch. Japan : JPMorgan Securities Japan Co., Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in Japan. Malaysia : This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X), which is a Participating Organization of Bursa Malaysia Berhad and holds a Capital Markets Services License issued by the Securities Commission in Malaysia. Mexico : J.P. Morgan Casa de Bolsa, S.A. de C.V. and J.P. Morgan Grupo Financiero are members of the Mexican Stock Exchange and are authorized to act as a broker dealer by the National Banking and Securities Exchange Commission. New Zealand : This material is issued and distributed by JPMSAL in New Zealand only to "wholesale clients" (as defined in the Financial Markets Conduct Act 2013). JPMSAL is registered as a Financial Service Provider under the Financial Service providers (Registration and Dispute Resolution) Act of 2008. Philippines : J.P. Morgan Securities Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Singapore : This material is issued and distributed in Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS) [MCI (P) 030/08/2023 and Co. Reg. No.: 199405335R], which is a member of the Singapore Exchange Securities Trading Limited, and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore), both of which are regulated by the Monetary Authority of Singapore. This material is issued and distributed in Singapore only to accredited investors, expert investors and institutional investors, as defined in Section 4A of the Securities and Futures Act, Cap. 289 (SFA). This material is not intended to be issued or distributed to any retail investors or any other investors that do not fall into the classes of “accredited investors,” “expert investors” or “institutional investors,” as defined under Section 4A of the SFA. Recipients of this material in Singapore are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection with, the material. South Africa : J.P. Morgan Equities South Africa Proprietary Limited and JPMorgan Chase Bank, N.A., Johannesburg Branch are members of the Johannesburg Securities Exchange and are regulated by the Financial Services Conduct Authority (FSCA). Taiwan : J.P. Morgan Securities (Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. Material relating to equity securities is issued and distributed in Taiwan by J.P. Morgan Securities (Taiwan) Limited, subject to the license scope and the applicable laws and the regulations in Taiwan. According to Paragraph 2, Article 7-1 of Operational Regulations Governing Securities Firms Recommending Trades in Securities to Customers (as amended or supplemented) and/or other applicable laws or regulations, please note that the recipient of this material is not permitted to engage in any activities in connection with the material that may give rise to conflicts of interests, unless otherwise disclosed in the “Important Disclosures” in this material. Thailand : This material is issued and distributed in Thailand by JPMorgan Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and Exchange Commission, and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok 10500. UK: Unless specified to the contrary, research is distributed in the UK by J.P. Morgan Securities plc (“JPMS plc”) which is a member of the London Stock Exchange and is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. JPMS plc is registered in England & Wales No. 2711006, Registered Office 25 Bank Street, London, E14 5JP. This material is directed in the UK only to: (a) persons having professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) (Order) 2005 (“the FPO”); (b) persons outlined in article 49 of the FPO (high net worth companies, unincorporated associations or partnerships, the trustees of high value trusts, etc.); or (c) any persons to whom this communication may otherwise lawfully be made; all such persons being referred to as "UK relevant persons". This material must not be acted on or relied on by persons who are not UK relevant persons. Any investment or investment activity to which this material relates is only available to UK relevant persons and will be engaged in only with UK relevant persons. Research issued by JPMS plc has been prepared in accordance with JPMS plc's policy for prevention and avoidance of conflicts of interest related to the production of Research which can be found at the following link: J.P. Morgan EMEA - Research Independence Policy. U.S .: J.P. Morgan Securities LLC (“JPMS”) is a member of the NYSE, FINRA, SIPC, and the NFA. JPMorgan Chase Bank, N.A. is a member of the FDIC. Material published by non-U.S. affiliates is distributed in the U.S. by JPMS who accepts responsibility for its content.

General: Additional information is available upon request. The information in this material has been obtained from sources believed to be reliable. While all reasonable care has been taken to ensure that the facts stated in this material are accurate and that the forecasts, opinions and expectations contained herein are fair and reasonable, JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) make no representations or warranties whatsoever to the completeness or accuracy of the material provided, except with respect to any disclosures relative to J.P. Morgan and the Research Analyst's involvement with the issuer that is the subject of the material. Accordingly, no reliance should be placed on the accuracy, fairness or completeness of the information contained in this material. There may be certain discrepancies with data and/or limited content in this material as a result of calculations, adjustments, translations to different languages, and/or local regulatory restrictions, as applicable. These discrepancies should not impact the overall investment analysis, views and/or recommendations of the subject company(ies) that may be discussed in the material. J.P. Morgan accepts no liability whatsoever for any loss arising from any use of this material or its contents, and neither J.P. Morgan nor any of its respective directors, officers or employees, shall be in any way responsible for the contents hereof, apart from the liabilities and responsibilities that may be imposed on them by the relevant regulatory authority in the jurisdiction in question, or the regulatory regime thereunder. Opinions, forecasts or projections contained in this material represent J.P. Morgan's current opinions or judgment as of the date of the material only and are therefore subject to change without notice. Periodic updates may be provided on companies/industries based on company-specific developments or announcements, market conditions or any other publicly available information. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or projections, which represent only one possible outcome. Furthermore, such opinions, forecasts or projections are subject to certain risks, uncertainties and assumptions that have not been verified, and future actual results or events could differ materially. The value of, or income from, any investments referred to in this material may fluctuate and/or be affected by changes in exchange rates. All pricing is indicative as of the close of market for the securities discussed, unless otherwise stated. Past performance is not indicative of future results. Accordingly, investors may receive back less than originally invested. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. This material may include views on structured securities, options, futures and other derivatives. These are complex instruments, may involve a high degree of risk and may be appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks involved. The recipients of this material must make their own independent decisions regarding any securities or financial instruments mentioned herein and should seek advice from such independent financial, legal, tax or other adviser as they deem necessary. J.P. Morgan may trade as a principal on the basis of the Research Analysts’ views and research, and it may also engage in transactions for its own account or for its clients’ accounts in a manner inconsistent with the views taken in this material, and J.P. Morgan is under no obligation to ensure that such other communication is brought to the attention of any recipient of this material. Others within J.P. Morgan, including Strategists, Sales staff and other Research Analysts, may take views that are inconsistent with those taken in this material. Employees of J.P. Morgan not involved in the preparation of this material may have investments in the securities (or derivatives of such securities) mentioned in this material and may trade them in ways different from those discussed in this material. This material is not an advertisement for or marketing of any issuer, its products or services, or its securities in any jurisdiction.

Confidentiality and Security Notice : This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. This message is subject to electronic monitoring: https://www.jpmorgan.com/disclosures/email

MSCI: Certain information herein (“Information”) is reproduced by permission of MSCI Inc., its affiliates and information providers (“MSCI”) ©2024. No reproduction or dissemination of the Information is permitted without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES (INCLUDING MERCHANTABILITY OR FITNESS) AS TO THE INFORMATION AND DISCLAIMS ALL LIABILITY TO THE EXTENT PERMITTED BY LAW. No Information constitutes investment advice, except for any applicable Information from MSCI ESG Research. Subject also to msci.com/disclaimer

Sustainalytics: Certain information, data, analyses and opinions contained herein are reproduced by permission of Sustainalytics and: (1) includes the proprietary information of Sustainalytics; (2) may not be copied or redistributed except as specifically authorized; (3) do not constitute investment advice nor an endorsement of any product or project; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Sustainalytics is not responsible for any trading decisions, damages or other losses related to it or its use. The use of the data is subject to conditions available at https://www.sustainalytics.com/legal-disclaimers. ©2024 Sustainalytics. All Rights Reserved.

"Other Disclosures" last revised April 06, 2024.

Copyright 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party. #$J&098$#*P

Completed 02 May 2024 11:46 AM BSTDisseminated 02 May 2024 11:46 AM BST